Document Type : Original Article

Authors

1 Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of nutrition, school of public health, Shahid Sadoughi university of medical scienses,Yazd,Iran

3 Department of Internal Medicine, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Department of Biostatistics and Epidemiology, Research Center of Prevention and Epidemiology of Non-Communicable Disease, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Abstract

obesity and diet are the most important risk factors for the development of osteoarthritis. L-carnitine is an anti-oxidant agent and increase energy expenditure. The aim of this study was to evaluate the efficacy of L-carnitine supplementation on the anthropometry measures in obese women with knee osteoarthritis.
Materials and Methods: This study was a randomized clinical trial in which 43 obese women with knee osteoarthritis were randomly assigned into two weight loss diet groups; the first one received the 1000 mg L-carnitine and with the second group took the placebo. Anthropometry indices such as height, weight, Body mass index (BMI), hip and waist circumference were assessed at the baseline and after 12 weeks from the start of intervention. Statistical analyses were carried out using SPSS (version16).
Results: Compared with the baseline, weight, BMI, waist and hip circumference decreased significantly in both groups after 12 weeks of intervention. However, no significant differences were observed between L-carnitine group and placebo group (P>0.05). But mean of changes waist circumference were significant between two groups (P=0.006)
Conclusion: According to the findings, oral administration of 1000 mg L-carnitine could decrease waist circumference but no significant effect observed on other anthropometry indices.

Keywords

Main Subjects

[1].   Mobasheri A, Henrotin Y. Biomarkers of (osteo) arthritis. Taylor & Francis; 2015.
[2].   Lee B-J, Lin J-S, Lin Y-C, Lin P-T. Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients. Nutrition 2015; 31(3):475-79.
[3].   Turkiewicz A, Petersson I, Björk J, Dahlberg L, Englund M. The consultation prevalence of osteoarthritis 2030 may increase by 50%: prognosis for Sweden. Osteoarthritis Cartilage 2013; 21: S160-S1.
[4].   Stevens-Lapsley JE, Kohrt WM. Osteoarthritis in women: effects of estrogen, obesity and physical activity. Women’s Health 2010; 6(4):601-15.
[5].   Palazzo C, Nguyen C, Lefevre-Colau M-M, Rannou F, Poiraudeau S. Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med 2016; 59(3): 134-38.
[6].   Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best practice & research Clinical rheumatology 2014; 28(1): 5-15.
[7].   Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis & Rheumatology 1987; 30(8): 914-8.
[8].   Aaboe J, Bliddal H, Messier S, Alkjaer T, Henriksen M. Effects of an intensive weight loss program on knee joint loading in obese adults with knee osteoarthritis. Osteoarthritis Cartilage. 2.8-822: (7) 19; 011.
[9].   Kreder HJ. Moderate weight loss improves functional disability but does not reduce pain in obese patients with knee osteoarthritis. ACP J Club 2007; 147(2): 43-.
[10].Pallu S, Francin P-J, Guillaume C, Gegout-Pottie P, Netter P, Mainard D et al. Obesity affects the chondrocyte responsiveness to leptin in patients with osteoarthritis. Arthritis Res Ther 2010; 12(3): R112.
[11]. Le Quintrec J-L, Verlhac B, Cadet C, Bréville P, Vetel JM, Gauvain JB, et al. Physical exercise and weight loss for hip and knee osteoarthritis in very old patients: a systematic review of the literature. The open rheumatology journal 2014; 8:89.
[12]. Ishiguro N, Kojima T, Poole AR. Mechanism of cartilage destruction in osteoarthritis 2002.
[13].Henrotin Y, Sanchez C, Bay-Jensen A, Mobasheri A. Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives. Ann Phys Rehabil Med 2016; 59(3):145-48.
[14].Alipour B, Barzegar A, Panahi F, Safaeian A. Effect of L-Carnitine Supplementation on Metabolic Status in Obese Diabetic Women With Hypocaloric Diet. Health scope 2014; 3 (1). )Persian(
[15].Hathcock JN, Shao A. Risk assessment for carnitine. Regul Toxicol Pharmacol 2006; 46(1): 23-28.
[16].Ahmadi S, Dehghan Banadaki S, Mozaffari-Khosravi H. Effects of Oral L-Carnitine Supplementation on Leptin and Adiponectin Levels and Body Weight of Hemodialysis Patients: a Randomized Clinical Trial. Iran J Kidney Dis 2016; 10(3): 144-50. )Persian(
[17].Pooyandjoo M, Nouhi M, Shab-Bidar S, Djafarian K, Olyaeemanesh A. The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 2016; 17(10): 970-76.)Persian(
[18].Samimi M, Jamilian M, Ebrahimi FA, Rahimi M, Tajbakhsh B, Asemi Z. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 2016; 84(6):851-57. )Persian(
[19].Derosa G, Cicero AF, Gaddi A, Mugellini A, Ciccarelli L, Fogari R. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 2003; 25(5): 1429-39. )Persian(
[20].Villani RG, Gannon J, Self M, Rich PA. L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int J Sport Nutr Exerc Metab 2000; 10(2):199-207.
[21].Vidal-Casariego A, Burgos-Peláez R, Martínez-Faedo C, Calvo-Gracia F, Valero-Zanuy M, Luengo-Pérez L et al. Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis. Experimental and clinical endocrinology & diabetes 2013; 121(04): 234-38.
[22]. Singhai A, Yadav V, Jha RK. Effect of L-carnitine supplementation on inflammatory marker of coronary artery disease. International Journal of Advances in Medicine 2017; 4(2): 467-70.